Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safer-use strategies in the context of harm-reduction treatment for people experiencing homelessness and alcohol use disorder.
Alawadhi YT, Shinagawa E, Taylor EM, Jackson C, Fragasso A, Howard M, Fan L, Kolpikova E, Karra S, Frohe T, Clifasefi SL, Duncan MH, Collins SE. Alawadhi YT, et al. Among authors: clifasefi sl. Int J Drug Policy. 2024 Jul;129:104448. doi: 10.1016/j.drugpo.2024.104448. Epub 2024 Jun 20. Int J Drug Policy. 2024. PMID: 38905941 Clinical Trial.
Randomized controlled trial of harm reduction treatment for alcohol (HaRT-A) for people experiencing homelessness and alcohol use disorder.
Collins SE, Clifasefi SL, Nelson LA, Stanton J, Goldstein SC, Taylor EM, Hoffmann G, King VL, Hatsukami AS, Cunningham ZL, Taylor E, Mayberry N, Malone DK, Jackson TR. Collins SE, et al. Among authors: clifasefi sl. Int J Drug Policy. 2019 May;67:24-33. doi: 10.1016/j.drugpo.2019.01.002. Epub 2019 Mar 6. Int J Drug Policy. 2019. PMID: 30851620 Free PMC article. Clinical Trial.
Combining behavioral harm-reduction treatment and extended-release naltrexone for people experiencing homelessness and alcohol use disorder in the USA: a randomised clinical trial.
Collins SE, Duncan MH, Saxon AJ, Taylor EM, Mayberry N, Merrill JO, Hoffmann GE, Clifasefi SL, Ries RK. Collins SE, et al. Among authors: clifasefi sl. Lancet Psychiatry. 2021 Apr;8(4):287-300. doi: 10.1016/S2215-0366(20)30489-2. Epub 2021 Mar 10. Lancet Psychiatry. 2021. PMID: 33713622 Free PMC article. Clinical Trial.
In their own words: Content analysis of pathways to recovery among individuals with the lived experience of homelessness and alcohol use disorders.
Collins SE, Jones CB, Hoffmann G, Nelson LA, Hawes SM, Grazioli VS, Mackelprang JL, Holttum J, Kaese G, Lenert J, Herndon P, Clifasefi SL. Collins SE, et al. Among authors: clifasefi sl. Int J Drug Policy. 2016 Jan;27:89-96. doi: 10.1016/j.drugpo.2015.08.003. Epub 2015 Aug 19. Int J Drug Policy. 2016. PMID: 26364078 Free PMC article.
Dual study describing patient-driven harm reduction goal-setting among people experiencing homelessness and alcohol use disorder.
Fentress TSP, Wald S, Brah A, Leemon G, Reyes R, Alkhamees F, Kramer M, Taylor EM, Wildhood M, Frohe T, Duncan MH, Clifasefi SL, Collins SE. Fentress TSP, et al. Among authors: clifasefi sl. Exp Clin Psychopharmacol. 2021 Jun;29(3):261-271. doi: 10.1037/pha0000470. Exp Clin Psychopharmacol. 2021. PMID: 34264737 Clinical Trial.
Harm reduction treatment for smoking (HaRT-S): findings from a single-arm pilot study with smokers experiencing chronic homelessness.
Collins SE, Nelson LA, Stanton J, Mayberry N, Ubay T, Taylor EM, Hoffmann G, Goldstein SC, Saxon AJ, Malone DK, Clifasefi SL, Okuyemi K; HaRT-S Community Advisory Board. Collins SE, et al. Among authors: clifasefi sl. Subst Abus. 2019;40(2):229-239. doi: 10.1080/08897077.2019.1572049. Epub 2019 Mar 29. Subst Abus. 2019. PMID: 30924732
30 results